186 related articles for article (PubMed ID: 37163869)
1. Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review.
Zhang E; Virk ZM; Rodriguez-Lopez J; Al-Samkari H
Thromb Res; 2023 Jun; 226():150-155. PubMed ID: 37163869
[TBL] [Abstract][Full Text] [Related]
2. Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia.
Virk ZM; Zhang E; Rodriguez-Lopez J; Witkin A; Wong AK; Luther J; Lin AE; Ning M; Grabowski E; Holbrook EH; Al-Samkari H
J Thromb Haemost; 2023 Jan; 21(1):26-36. PubMed ID: 36695393
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasia.
Virk ZM; Richardson TL; Al-Samkari H
J Thromb Thrombolysis; 2023 Aug; 56(2):355-359. PubMed ID: 37340288
[TBL] [Abstract][Full Text] [Related]
4. Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation.
Pepe M; Suppressa P; Giuliano AF; Nestola PL; Bortone AS; DE Cillis E; Acquaviva T; Forleo C; Moscarelli M; Lenato GM; Sabbà C
Minerva Cardiol Angiol; 2022 Oct; 70(5):537-544. PubMed ID: 33703853
[TBL] [Abstract][Full Text] [Related]
5. Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation.
Edwards CP; Shehata N; Faughnan ME
Ann Hematol; 2012 Dec; 91(12):1959-68. PubMed ID: 23053175
[TBL] [Abstract][Full Text] [Related]
6. Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia.
Shovlin CL; Millar CM; Droege F; Kjeldsen A; Manfredi G; Suppressa P; Ugolini S; Coote N; Fialla AD; Geisthoff U; Lenato GM; Mager HJ; Pagella F; Post MC; Sabbà C; Sure U; Torring PM; Dupuis-Girod S; Buscarini E;
Orphanet J Rare Dis; 2019 Aug; 14(1):210. PubMed ID: 31462308
[TBL] [Abstract][Full Text] [Related]
7. Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians.
Al-Samkari H
Semin Thromb Hemost; 2022 Jul; 48(5):514-528. PubMed ID: 35226946
[TBL] [Abstract][Full Text] [Related]
8. Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group.
Gaetani E; Agostini F; Porfidia A; Giarretta I; Feliciani D; Di Martino L; Tortora A; Gasbarrini A; Pola R;
Orphanet J Rare Dis; 2019 Dec; 14(1):298. PubMed ID: 31878955
[TBL] [Abstract][Full Text] [Related]
9. High Rates of Bleeding Complications among Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia in the United States.
Brinjikji W; Wood CP; Lanzino G; Cloft HJ; Misra S; Kallmes DF; Kamath P; Pruthi RK; Krowka MJ; Swanson KL; Iyer VN
Ann Am Thorac Soc; 2016 Sep; 13(9):1505-11. PubMed ID: 27387823
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL).
Grobost V; Hammi S; Pereira B; Guilhem A; Duffau P; Seguier J; Parrot A; Gautier G; Alric L; Kerjouan M; Le Guillou X; Simon D; Chaussavoine L; Rondeau-Lutz M; Leguy-Seguin V; Delagrange L; Lavigne C; Maillard H; Dupuis-Girod S;
Thromb Res; 2023 Sep; 229():107-113. PubMed ID: 37437516
[TBL] [Abstract][Full Text] [Related]
11. Hereditary hemorrhagic telangiectasia-related epistaxis: innovations in understanding and management.
Sautter NB; Smith TL
Int Forum Allergy Rhinol; 2012; 2(5):422-31. PubMed ID: 22566463
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
[TBL] [Abstract][Full Text] [Related]
13. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry.
Gaetani E; Agostini F; Giarretta I; Porfidia A; Di Martino L; Gasbarrini A; Pola R; On Behalf Of The Multidisciplinary Gemelli Hospital Group For Hht
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32498318
[TBL] [Abstract][Full Text] [Related]
15. Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.
Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
Otolaryngol Head Neck Surg; 2020 Jan; 162(1):8-25. PubMed ID: 31910122
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life.
Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM
Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465
[TBL] [Abstract][Full Text] [Related]
17. Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care.
Al-Samkari H
Blood; 2021 Feb; 137(7):888-895. PubMed ID: 33171488
[TBL] [Abstract][Full Text] [Related]
18. Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding.
Beckman JD; Li Q; Hester ST; Leitner O; Smith KL; Kasthuri RS
Orphanet J Rare Dis; 2020 Jul; 15(1):185. PubMed ID: 32660636
[TBL] [Abstract][Full Text] [Related]
19. Clinical Practice Guideline: Nosebleed (Epistaxis).
Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
Otolaryngol Head Neck Surg; 2020 Jan; 162(1_suppl):S1-S38. PubMed ID: 31910111
[TBL] [Abstract][Full Text] [Related]
20. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry.
Riera-Mestre A; Mora-Luján JM; Trujillo-Santos J; Del Toro J; Nieto JA; Pedrajas JM; López-Reyes R; Soler S; Ballaz A; Cerdà P; Monreal M;
Orphanet J Rare Dis; 2019 Aug; 14(1):196. PubMed ID: 31399146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
